Beam Therapeutics Inc., of Cambridge, Mass., appointed Giuseppe Ciaramella president and chief scientific officer.
Eli Lilly and Co., of Indianapolis, appointed Anat Hakim senior vice president and general counsel, effective Feb. 3.
Galapagos NV, of Mechelen, Belgium, appointed Michele Manto chief commercial officer.
Hoverink Biotechnologies Inc., of Los Angeles, appointed Cyrus Sajna CEO and chief financial officer.
Kura Oncology Inc., of San Diego, appointed Bridget Martell acting chief medical officer.
Polyphor AG, of Allschwil, Switzerland, appointed Gökhan Batur CEO.
Santhera Pharmaceuticals AG, of Pratteln, Switzerland, appointed Andrew Smith chief financial officer.